Drug recall
Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per…
FDA recall event 63913 · Class II · Hospira, Inc.
Key facts
| Event ID | 63913 |
|---|---|
| Recall numbers | D-099-2013 |
| Recalling firm | Hospira, Inc. |
| Product type | Drugs |
| Products | Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02. |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in… |
| Initiation date | Oct 4, 2012 |
| Report date | Dec 26, 2012 |
| Termination date | May 8, 2014 |
| City | Lake Forest |
| State | IL |
| Country | United States |
| FEI number | 3003940565 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: